方盛制药涨5.08% 创近8个月新高政策红利与估值切换驱动

智选洞察2025-07-29

方盛制药股价今日表现强势，截至13点04分，最新价报11.37元/股，上涨5.08%，创近8个月新高。政策博弈与估值切换驱动短期波动方盛制药近期股价波动与资金高频调仓密切相关。截至7月25日，主力资金近5个交易日累计净流出约1049万元，期间单日资金流向多次切换，反映市场分歧加剧。程序化交易新规实施后，部分机构加速向科技、资源板块迁移，医药板块整体承压。但中药材价格指数回落及创新药集采豁免政策形成...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2555084247?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-29 13:05","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2555084247","market":"sh","top_or_hot":-1,"title":"方盛制药涨5.08% 创近8个月新高 政策红利与估值切换驱动","media":"智选洞察","content":"<div>\n<p>方盛制药股价今日表现强势，截至13点04分，最新价报11.37元/股，上涨5.08%，创近8个月新高。政策博弈与估值切换驱动短期波动方盛制药近期股价波动与资金高频调仓密切相关。截至7月25日，主力资金近5个交易日累计净流出约1049万元，期间单日资金流向多次切换，反映市场分歧加剧。程序化交易新规实施后，部分机构加速向科技、资源板块迁移，医药板块整体承压。但中药材价格指数回落及创新药集采豁免政策形成...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729130526a468ee42&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>方盛制药涨5.08% 创近8个月新高 政策红利与估值切换驱动</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n方盛制药涨5.08% 创近8个月新高 政策红利与估值切换驱动\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-29 13:05 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729130526a468ee42&s=b><strong>智选洞察</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>方盛制药股价今日表现强势，截至13点04分，最新价报11.37元/股，上涨5.08%，创近8个月新高。政策博弈与估值切换驱动短期波动方盛制药近期股价波动与资金高频调仓密切相关。截至7月25日，主力资金近5个交易日累计净流出约1049万元，期间单日资金流向多次切换，反映市场分歧加剧。程序化交易新规实施后，部分机构加速向科技、资源板块迁移，医药板块整体承压。但中药材价格指数回落及创新药集采豁免政策形成...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729130526a468ee42&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"603998","symbol_name":"方盛制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729130526a468ee42&s=b","article_id":"2555084247","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729130526a468ee42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2555084247","pubTimestamp":1753765524,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"方盛制药股价今日表现强势，截至13点04分，最新价报11.37元/股，上涨5.08%，创近8个月新高。政策博弈与估值切换驱动短期波动方盛制药近期股价波动与资金高频调仓密切相关。但中药材价格指数回落及创新药集采豁免政策形成对冲效应，吸引部分资金在估值洼地布局。研发护城河与政策红利支撑价值重估方盛制药长期成长性由研发积累与行业集中度提升双重驱动。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603998":"方盛制药","BK0060":"抗癌","BK0239":"医药制造"},"translate_title":"Fangsheng Pharmaceutical rose 5.08%, hitting a new high in the past 8 months, driven by policy dividends and valuation switching","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603998":1},"content_text":"方盛制药股价今日表现强势，截至13点04分，最新价报11.37元/股，上涨5.08%，创近8个月新高。政策博弈与估值切换驱动短期波动方盛制药近期股价波动与资金高频调仓密切相关。截至7月25日，主力资金近5个交易日累计净流出约1049万元，期间单日资金流向多次切换，反映市场分歧加剧。程序化交易新规实施后，部分机构加速向科技、资源板块迁移，医药板块整体承压。但中药材价格指数回落及创新药集采豁免政策形成对冲效应，吸引部分资金在估值洼地布局。叠加中药Ⅱ板块市净率处于十年低位，高切低策略进一步放大股价波动幅度。7月29日盘中，该股最高触及11.38元，振幅达6.19%，资金博弈特征明显。研发护城河与政策红利支撑价值重估方盛制药长期成长性由研发积累与行业集中度提升双重驱动。2024年公司净利润同比增长36%至2.55亿元，心脑血管用药收入占比提升至29.85%，7项中药创新药中已有2项获批。随着《中医药振兴发展重大工程实施方案》落地，具备独家品种的企业有望持续受益。当前公司市盈率18.28倍，较行业均值仍存折价空间。技术面上，股价站稳10.86元关键位后，中期上行通道逐步形成。湘财证券指出，政策红利释放与成本管控能力将成为估值修复关键变量，但需关注2024年前三季度原材料成本占比上升1.2个百分点带来的利润端压力。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2555084247","isCrawlerRequest":true}

方盛制药涨5.08% 创近8个月新高 政策红利与估值切换驱动

精彩评论

方盛制药涨5.08% 创近8个月新高政策红利与估值切换驱动